Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EPCORITAMAB-BYSP Cause Neurotoxicity? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Neurotoxicity have been filed in association with EPCORITAMAB-BYSP. This represents 0.8% of all adverse event reports for EPCORITAMAB-BYSP.

8
Reports of Neurotoxicity with EPCORITAMAB-BYSP
0.8%
of all EPCORITAMAB-BYSP reports
5
Deaths
4
Hospitalizations

How Dangerous Is Neurotoxicity From EPCORITAMAB-BYSP?

Of the 8 reports, 5 (62.5%) resulted in death, 4 (50.0%) required hospitalization, and 2 (25.0%) were considered life-threatening.

Is Neurotoxicity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EPCORITAMAB-BYSP. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does EPCORITAMAB-BYSP Cause?

Cytokine release syndrome (369) Diffuse large b-cell lymphoma (206) Diffuse large b-cell lymphoma refractory (198) Pyrexia (79) Immune effector cell-associated neurotoxicity syndrome (77) Covid-19 (39) Neutrophil count decreased (35) Hypogammaglobulinaemia (32) Platelet count decreased (32) Cytomegalovirus infection (31)

What Other Drugs Cause Neurotoxicity?

AXICABTAGENE CILOLEUCEL (1,327) OXALIPLATIN (1,272) METHOTREXATE (1,083) CYCLOPHOSPHAMIDE (763) FLUOROURACIL (735) PACLITAXEL (734) TACROLIMUS (623) BEVACIZUMAB (588) VINCRISTINE (555) CAPECITABINE (553)

Which EPCORITAMAB-BYSP Alternatives Have Lower Neurotoxicity Risk?

EPCORITAMAB-BYSP vs EPERISONE EPCORITAMAB-BYSP vs EPHEDRINE EPCORITAMAB-BYSP vs EPINASTINE EPCORITAMAB-BYSP vs EPINEPHRINE EPCORITAMAB-BYSP vs EPINEPHRINE\LIDOCAINE

Related Pages

EPCORITAMAB-BYSP Full Profile All Neurotoxicity Reports All Drugs Causing Neurotoxicity EPCORITAMAB-BYSP Demographics